Shilajit in Thailand: Is It Legal? Thai FDA Status, Risks, and Market Reality
In recent years, Shilajit has gained global popularity as a dietary supplement, particularly in markets such as the United States and India. However, companies looking to introduce Shilajit into Thailand face a very different regulatory landscape.
This article provides a clear, technical answer to a common question:
Can Shilajit be legally sold or registered in Thailand?
Short Answer: No
As of today:
- Shilajit is not approved in Thailand
- It is not registrable as a dietary supplement
- It is not recognized under Thai traditional medicine
- There are no approved products on the market
- Products currently sold online are non-compliant
Thai FDA Position on Shilajit
The Thai Food and Drug Administration (TFDA) regulates food supplements under a structured framework based on:
- Approved ingredient lists
- Recognized herbal substances
- Safety and quality standards
Shilajit does not fit into any of these categories.
1. Not a Recognized Food Ingredient
Shilajit is:
- A mineral-organic exudate (often referred to as “mineral pitch”)
- Highly variable in composition
- Not included in Thai FDA positive lists
This creates a fundamental issue: There is no clear regulatory classification pathway
2. Not Accepted as a Herbal Product
Thailand recognizes Thai traditional medicine, not Ayurvedic substances by default.
- Shilajit is widely used in Ayurveda (India)
- It is not included in the Thai Herbal Pharmacopoeia
Result: It cannot be registered as a traditional or herbal product in Thailand
Shilajit as Novel Food? In Theory Yes — In Practice No
One might argue that Shilajit could be submitted as a novel food.
However, this route is not viable in practice.
Why?
A novel food submission would require:
- Full toxicological profile
- Standardized composition
- Reproducible manufacturing process
- Comprehensive safety data
Shilajit typically fails on all critical points:
- Highly variable composition
- Difficult to standardize
- Frequent contamination concerns (heavy metals such as lead, arsenic, mercury)
Conclusion: A novel food safety assessment would very likely fail
Contamination Risk: A Major Regulatory Barrier
One of the main reasons regulators reject Shilajit is safety risk.
Typical issues include:
- Heavy metals exceeding permissible limits
- Environmental contamination
- Lack of pharmaceutical-grade purification
Thai FDA applies strict limits on:
- Lead (Pb)
- Arsenic (As)
- Mercury (Hg)
- Cadmium (Cd)
Shilajit, by nature, is considered a high-risk raw material
Market Reality in Thailand
Despite the regulatory situation, Shilajit products can still be found:
- On e-commerce platforms
- Through social media sellers
- Via informal import channels
These products are:
- Not registered
- Not approved
- Not compliant with Thai law
In simple terms: They are illegal
Why You See Shilajit Online Anyway
This is a classic case of:
- Weak enforcement in digital channels
- Cross-border e-commerce leakage
- Mislabeling or deliberate misclassification
However, this does not change the regulatory status.
Illegally sold ≠ legally accepted
Can It Be Made Compliant?
At present, there are only theoretical options:
1. Reformulation
Extracting and isolating specific compounds (e.g. fulvic acid)
→ but this becomes a different product, not Shilajit
2. Cosmetic Route
Inclusion as a cosmetic ingredient
→ highly questionable and still risky
3. Exclude Thailand
Launch in markets where Shilajit is accepted
→ most realistic strategy
Conclusion
Shilajit is a clear example of a product that is:
- Popular globally
- Commercially attractive
- Regulatorily blocked in Thailand
As of today:
- ❌ Not approved
- ❌ Not registrable
- ❌ Not aligned with Thai FDA frameworks
- ❌ Not viable as a novel food
- ❌ Currently sold only through non-compliant channels
Need a Regulatory Feasibility Assessment?
If you are evaluating the Thai market for complex or borderline ingredients, a pre-assessment is critical before investing in product development or market entry.
At Siam Trade Development, we support companies with:
- Ingredient classification
- Regulatory feasibility analysis
- Thai FDA strategy and submissions

